These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Orbital fat expansion in thyroid eye disease is related to age. Ugradar S; Rootman DB Eur J Ophthalmol; 2020 Sep; 30(5):1004-1007. PubMed ID: 31144509 [TBL] [Abstract][Full Text] [Related]
24. Whole-orbit-based multiparametric assessment of disease activity of thyroid eye disease on Dixon MRI. Xia D; Zhang H; Wang H; Jiang M; Tang Y; Li Y; Sun J; Song X; Zhou H Int Ophthalmol; 2024 May; 44(1):213. PubMed ID: 38700596 [TBL] [Abstract][Full Text] [Related]
25. Usefulness of the ratio of orbital fat to total orbit area in mild-to-moderate thyroid-associated ophthalmopathy. Kim HC; Yoon SW; Lew H Br J Radiol; 2015 Sep; 88(1053):20150164. PubMed ID: 26151616 [TBL] [Abstract][Full Text] [Related]
26. Radiologic imaging shows variable accuracy in diagnosing orbital inflammatory disease and assessing its activity. Lee MJ; Hamilton BE; Pettersson D; Ogle K; Murdock J; Dailey RA; Ng JD; Steele EA; Verma R; Planck SR; Martin TM; Choi D; Rosenbaum JT Sci Rep; 2020 Dec; 10(1):21875. PubMed ID: 33318556 [TBL] [Abstract][Full Text] [Related]
27. Graves ophthalmopathy: the bony orbit in optic neuropathy, its apical angular capacity, and impact on prediction of risk. Chan LL; Tan HE; Fook-Chong S; Teo TH; Lim LH; Seah LL AJNR Am J Neuroradiol; 2009 Mar; 30(3):597-602. PubMed ID: 19147718 [TBL] [Abstract][Full Text] [Related]
28. Correlation between extraocular muscle size and motility restriction in thyroid eye disease. Dagi LR; Zoumalan CI; Konrad H; Trokel SL; Kazim M Ophthalmic Plast Reconstr Surg; 2011; 27(2):102-10. PubMed ID: 21383547 [TBL] [Abstract][Full Text] [Related]
29. Correlation of Automated Computed Tomography Volumetric Analysis Metrics With Motility Disturbances in Thyroid Eye Disease. Law JJ; Mundy KM; Kupcha AC; Chaganti S; Nelson KM; Harrigan RL; Landman BA; Mawn LA Ophthalmic Plast Reconstr Surg; 2021 Jul-Aug 01; 37(4):372-376. PubMed ID: 33229950 [TBL] [Abstract][Full Text] [Related]
30. Clinical challenge: An orbital Hickam's dictum. Wilson ME; Thornton S; Murchison AP; Bilyk JR Surv Ophthalmol; 2016; 61(6):799-805. PubMed ID: 26994869 [TBL] [Abstract][Full Text] [Related]
31. Age-Related Changes in the Clinical Phenotype of Compressive Optic Neuropathy in Thyroid Eye Disease. Campbell AA; Nanda T; Oropesa S; Kazim M Ophthalmic Plast Reconstr Surg; 2019; 35(3):238-242. PubMed ID: 30234838 [TBL] [Abstract][Full Text] [Related]
32. Orbital Angiogenesis and Lymphangiogenesis in Thyroid Eye Disease: An Analysis of Vascular Growth Factors with Clinical Correlation. Wong LL; Lee NG; Amarnani D; Choi CJ; Bielenberg DR; Freitag SK; D'Amore PA; Kim LA Ophthalmology; 2016 Sep; 123(9):2028-36. PubMed ID: 27423310 [TBL] [Abstract][Full Text] [Related]
33. Effect of orbital bony decompression for Graves' orbitopathy on the volume of extraocular muscles. Alsuhaibani AH; Carter KD; Policeni B; Nerad JA Br J Ophthalmol; 2011 Sep; 95(9):1255-8. PubMed ID: 21216797 [TBL] [Abstract][Full Text] [Related]
34. Temporal Fat Pad Volume in Patients With Thyroid Eye Disease. Choudhary MM; Zhang KR; Johnson S; Hwang CJ; Chon BH; Perry JD Ophthalmic Plast Reconstr Surg; 2020; 36(2):194-197. PubMed ID: 31743280 [TBL] [Abstract][Full Text] [Related]
35. [Bony orbital decompression in thyroid eye disease]. Grusha YO; Kochetkov PA; Sviridenko NY; Kolodina AS; Dzamikhov IK Vestn Oftalmol; 2024; 140(1):103-108. PubMed ID: 38450474 [TBL] [Abstract][Full Text] [Related]
36. Immune-related visual dysfunction in thyroid eye disease: a combined orbital and brain neuroimaging study. Zhang H; Liu Y; Jiang M; Shen F; Zhu T; Xia D; Li J; Fang S; Li Y; Sun J; Song X; Zhou H; Fan X Eur Radiol; 2024 Jul; 34(7):4516-4526. PubMed ID: 38112763 [TBL] [Abstract][Full Text] [Related]
37. Reactivation of thyroid eye disease following extraocular muscle surgery. Xu L; Glass LR; Kazim M Ophthalmic Plast Reconstr Surg; 2014; 30(1):e5-6. PubMed ID: 23467286 [TBL] [Abstract][Full Text] [Related]
38. Sinus opacification associated with exacerbation of thyroid eye disease. Abazari A; Chak G; Feldon SE Ophthalmic Plast Reconstr Surg; 2010; 26(4):233-7. PubMed ID: 20502367 [TBL] [Abstract][Full Text] [Related]
39. Extraocular Muscle Enlargement and Thyroid Eye Disease-like Orbital Inflammation Associated with Immune Checkpoint Inhibitor Therapy in Cancer Patients. Sagiv O; Kandl TJ; Thakar SD; Thuro BA; Busaidy NL; Cabanillas M; Jimenez C; Dadu R; Graham PH; Debnam JM; Esmaeli B Ophthalmic Plast Reconstr Surg; 2019; 35(1):50-52. PubMed ID: 29927883 [TBL] [Abstract][Full Text] [Related]
40. In vivo ocular biomechanical compliance in thyroid eye disease. Vellara HR; Hart R; Gokul A; McGhee CNJ; Patel DV Br J Ophthalmol; 2017 Aug; 101(8):1076-1079. PubMed ID: 27941044 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]